Bone Marrow Transplant in India for Overseas Patients: Cost, Hospitals & Process

For overseas patients considering a stem cell transplant in India, choosing the right transplant centre is only the first step. The patient's diagnosis, disease stage, donor availability, transplant type, previous treatment and overall health all affect the medical plan.

A bone marrow transplant, also called a hematopoietic stem cell transplant (HSCT), replaces damaged or diseased blood-forming stem cells with healthy stem cells. Depending on the condition, the cells may come from the patient or a donor. The treatment is used for selected blood cancers, bone marrow failure disorders and certain inherited blood conditions.

India has established transplant programmes in several large hospitals. HealthRoop's hospital currently lists Apollo Hospitals, Fortis Healthcare, Medanta – The Medicity, Narayana Health, Manipal Hospitals, Max Healthcare and HCG Cancer Centre among hospitals with relevant oncology, haematology or BMT facilities.

For an overseas patient, the important question is not simply which hospital is famous. It is whether the centre has the right transplant programme for the patient's particular disease and donor situation.

What Is a Bone Marrow Transplant?

A bone marrow transplant is a treatment in which healthy blood-forming stem cells are given to a patient after conditioning treatment has prepared the body to receive them.

The term "bone marrow transplant" is still widely used, although stem cells can be collected from peripheral blood rather than directly from bone marrow.

A transplant may be considered for conditions such as:

• Acute myeloid leukaemia (AML)
• Acute lymphoblastic leukaemia (ALL)
• Certain lymphomas
• Multiple myeloma
• Myelodysplastic syndromes
• Aplastic anaemia
• Thalassaemia
• Sickle cell disease
• Certain inherited immune or metabolic disorders

Not every patient with one of these conditions needs a transplant. The decision is made by a haematologist or transplant physician after reviewing the diagnosis, disease status, previous treatment and the expected benefits and risks.

Types of Bone Marrow Transplant Available in India

The type of transplant is one of the biggest factors affecting treatment planning and cost.

Autologous Stem Cell Transplant

In an autologous transplant, the patient's own stem cells are collected before high-dose treatment and stored for later infusion.

It is commonly used in selected patients with conditions such as multiple myeloma and certain lymphomas.

Main steps include:

• Disease assessment
• Stem cell mobilisation
• Stem cell collection through apheresis
• Conditioning therapy
• Stem cell infusion
• Blood-count and infection monitoring
• Recovery and follow-up

Because the patient's own cells are used, there is no donor matching requirement. However, the treatment still requires careful monitoring for infection, low blood counts and other complications.

Allogeneic Stem Cell Transplant

In an allogeneic transplant, stem cells come from another person.

The donor may be:

• A matched sibling
• Another matched family member
• A matched unrelated donor
• A partially matched family donor, depending on the treatment programme

HLA typing is important because the patient's immune system and donor cells need to be compatible enough for transplantation.

Allogeneic transplantation is more complex than autologous transplantation and can involve complications such as graft-versus-host disease (GVHD), infections and prolonged immune suppression.

Haploidentical Transplant

A haploidentical transplant uses a partially matched family donor, often a parent, child or sibling.

This approach can be useful when a fully matched donor is not available, but the suitability depends on the disease and the transplant team's assessment.

What Is the Bone Marrow Transplant Cost in India?

The bone marrow transplant cost in India can vary widely. A reasonable planning range for treatment in private Indian hospitals is approximately ₹15 lakh to ₹40 lakh or more, depending on the transplant type and complexity.

Published Indian sources have reported private-hospital costs around ₹15–30 lakh in some settings, while other estimates extend to ₹40 lakh or more for complex cases. Public-sector costs can be substantially lower, but availability, eligibility and international-patient access are different considerations.

Indicative BMT Cost in India

Resource: Indicative ranges have been compiled from published Indian hospital and healthcare cost references, including Apollo Hospitals, CARE Hospitals and Indian healthcare reporting. Actual hospital quotations vary by patient and treatment plan.

Why Can the Final BMT Bill Be Higher?

The transplant itself is only one part of the treatment.

The total cost may include:

• Initial consultation
• Bone marrow biopsy
• Blood tests
• HLA typing
• Donor search
• Infection screening
• Organ-function testing
• Stem cell collection
• Conditioning chemotherapy
• Stem cell processing
• Transplant admission
• Isolation-room charges
• Antibiotics and antifungal medicines
• Blood and platelet transfusions
• Immunosuppressive medicines
• ICU care, if required
• Treatment of infections
• GVHD management
• Follow-up investigations

This is why overseas patients should ask for an itemised quotation rather than relying on a single advertised BMT price.

What Factors Affect BMT Cost in India?

Several clinical and practical factors can change the final amount.

1. Type of Transplant

Autologous transplantation is generally less complex than allogeneic transplantation. Donor-related procedures and additional immune-management requirements can increase the cost of an allogeneic transplant.

2. Donor Matching

A matched sibling donor can make the process different from an unrelated or partially matched donor.

HLA typing and donor-related testing may add to the pre-transplant expenses.

3. Disease Being Treated

The treatment pathway for leukaemia is not identical to that for multiple myeloma, lymphoma or thalassaemia.

4. Previous Treatment

Patients who have already received chemotherapy, radiation or other treatments may require a more detailed assessment before transplantation.

5. Length of Hospital Stay

The patient usually remains under close monitoring during the period when blood counts are low and the transplanted cells begin to establish themselves.

6. Complications

Infections, GVHD, bleeding, organ problems or delayed engraftment can increase hospitalisation and medication costs.

7. Hospital and Room Category

Costs differ between hospitals and room categories. International patients should check whether the quotation includes isolation facilities, nursing, medicines and diagnostic monitoring.

How Does a Bone Marrow Transplant Work?

A BMT is not a single-day procedure. It is a treatment programme that starts before the stem cells are infused and continues through recovery.

Step 1: Medical Evaluation

The transplant team reviews:

• Diagnosis
• Disease status
• Previous treatment
• Blood counts
• Bone marrow reports
• Kidney and liver function
• Heart and lung function
• Infection status
• HLA results
• Donor availability

The purpose is to determine whether transplantation is medically appropriate.

Step 2: Donor Evaluation

For allogeneic transplantation, the team identifies a suitable donor.

The process may begin with family HLA testing. If a suitable related donor is unavailable, the medical team may consider an unrelated or partially matched donor according to the patient's condition and available options.

Step 3: Stem Cell Collection

For an autologous transplant, the patient's stem cells are mobilised and collected.

For many allogeneic transplants, stem cells are collected from the donor's bloodstream using apheresis. In some circumstances, marrow collection may be used.

Step 4: Conditioning Treatment

The patient receives chemotherapy, with or without radiation, to prepare the body for transplantation.

The intensity depends on the disease, patient's age, general health and transplant protocol.

Step 5: Stem Cell Infusion

The collected stem cells are infused through an intravenous line.

The infusion itself is generally not comparable to major surgery. The more demanding part of the treatment is the period before and after infusion, when blood counts and immunity can be very low.

Step 6: Engraftment

The transplanted cells begin producing new blood cells.

During this period, doctors monitor:

• White blood cells
• Red blood cells
• Platelets
• Infection markers
• Organ function
• Signs of GVHD in allogeneic transplantation

Step 7: Post-Transplant Monitoring

Recovery continues after discharge. Regular blood tests and specialist reviews remain important because some complications can occur weeks or months after transplantation.

How Long Does a Bone Marrow Transplant Take?

The total treatment period varies from patient to patient.

For an overseas patient, planning several weeks in India is usually more realistic than arranging a short hospital visit. HealthRoop's BMT information currently advises many patients to plan approximately 6–8 weeks in India for the pre-transplant assessment, transplant, early recovery and initial monitoring, although some patients require longer stays.

The exact duration depends on:

• Disease status
• Transplant type
• Donor availability
• Conditioning protocol
• Engraftment
• Infection risk
• Complications
• Recovery after discharge

Families should not book return flights based on a fixed number of days before the transplant team provides a clinical timeline.

Best BMT Hospital in India: Hospitals to Consider

There is no medically responsible way to name one best BMT hospital in India for every patient.

A suitable hospital should have experience with the patient's disease, transplant type, age group and donor situation. The following hospitals are taken from HealthRoop's current hospital network rather than from an unrelated hospital ranking.

Apollo Hospitals

Apollo's hospital network includes oncology services, PET-CT and international patient facilities. Its listed international services include visa assistance, airport transfers, language interpreters, second opinions and post-discharge follow-up.

For an overseas patient, the key step is to identify the specific Apollo centre and transplant team appropriate for the diagnosis.

Fortis Healthcare

Fortis lists oncology as one of its major specialties and provides international patient services, translation support, accommodation assistance and medical-record management. Its network also includes advanced radiation therapy facilities.

Patients should ask which Fortis location has the appropriate BMT programme for their condition.

Medanta – The Medicity

Medanta in Gurugram has a Cancer Institute and lists a stem cell laboratory among its facilities. Its international patient services include visa-letter issuance, airport transfers, interpreter services and video second opinions.

This can be relevant for overseas patients who need coordinated care across haematology, oncology and other specialties.

Narayana Health

Narayana Health's hospital network lists oncology and a bone marrow transplant unit, along with an international patient desk, travel and visa support, online consultations and post-treatment teleconsultation.

These services can be particularly useful because BMT follow-up continues after the patient leaves India.

Manipal Hospitals

Manipal Hospitals lists oncology and a bone marrow transplant facility within its network. International patient services include travel assistance, language support, medical visa assistance, accommodation booking and dedicated coordinators.

Patients should confirm the specific campus and transplant programme before finalising travel.

Max Healthcare

Max Healthcare's listed oncology services include access to PET-CT, advanced ICU facilities and international patient support. Its international division provides visa invitation letters, airport transfers, guest-house facilities and insurance coordination.

HCG Cancer Centre

HCG is particularly relevant to patients looking for a cancer-focused network. Its HealthRoop listing includes medical oncology, radiation therapy, surgical oncology and bone marrow transplant, along with tumour-board reviews, cancer second opinions, genetic counselling and international patient services.

BMT Hospital Comparison for Overseas Patients

Resource: HealthRoop hospital directory, which lists the above hospitals and their reported specialties, facilities and international-patient services.

Who May Need a Bone Marrow Transplant?

BMT may be considered when healthy blood-forming stem cells can help replace damaged marrow or provide a new blood-forming system.

Conditions commonly evaluated for transplantation include:

Blood Cancers

• Acute leukaemia
• Certain lymphomas
• Multiple myeloma
• Myelodysplastic syndromes

Bone Marrow Failure

• Aplastic anaemia
• Selected marrow-failure syndromes

Inherited Blood Disorders

• Thalassaemia
• Sickle cell disease
• Selected inherited immune disorders

The decision depends on the individual case. Diagnosis alone does not mean that BMT is automatically required.

What Documents Should Overseas Patients Send Before Travelling?

International patients should send their complete medical file before booking treatment.

Medical records checklist

• Recent haematology reports
• Bone marrow biopsy report
• Flow cytometry report, where applicable
• Cytogenetic or molecular testing
• PET-CT, CT or MRI reports
• Actual scan images where available
• Previous chemotherapy records
• Radiation records
• Surgical reports
• Blood transfusion history
• Infection-screening reports
• Current medication list
• HLA reports, if already performed
• Donor information, if available
• Previous discharge summaries

Sending only the diagnosis is not enough for a transplant quotation.

A transplant team needs to know the patient's current disease status and previous treatment before determining whether transplantation is appropriate.

Do Overseas Patients Need a Donor Before Coming to India?

Not necessarily.

For an allogeneic transplant, a matched sibling is often considered first when available. If there is no suitable family donor, the transplant team may evaluate other donor options.

The patient should not independently arrange a donor without guidance from the transplant centre.

The hospital may need to conduct:

• HLA typing
• Donor evaluation
• Infectious-disease screening
• Medical fitness assessment
• Additional compatibility testing

The donor process can affect both treatment timing and cost.

What Should International Patients Ask Before Choosing a BMT Centre?

Before accepting a hospital quotation, ask these questions:

Medical questions

• Is transplantation appropriate for my diagnosis?
• Which transplant type is recommended?
• What is my current disease status?
• Do I need further chemotherapy first?
• What donor type is preferred?
• Is HLA testing required again?
• What conditioning regimen is planned?
• What are the major transplant-related risks?
• How long will I need to remain near the hospital?
• What follow-up is required after returning home?

Financial questions

• What is included in the package?
• Is donor testing included?
• Is HLA typing included?
• Are medicines included?
• Are blood products included?
• Is isolation-room care included?
• What happens if the patient develops an infection?
• What happens if ICU care is required?
• Are post-discharge tests included?
• How long is the quotation valid?

This list can prevent major differences between the expected cost and the final hospital bill.

What Are the Main Risks of Bone Marrow Transplant?

BMT is a major treatment and should not be viewed as a simple procedure.

Possible complications include:

• Serious infections
• Low blood counts
• Bleeding
• Anaemia
• Mucositis
• Nausea and loss of appetite
• Organ complications
• Infertility
• Graft-versus-host disease after allogeneic transplantation
• Delayed engraftment
• Disease relapse

The risk varies according to the patient's disease, age, transplant type, conditioning regimen and overall health.

The transplant physician should explain both the expected benefit and the potential risks before treatment.

Recovery After Bone Marrow Transplant

Recovery does not end when the patient leaves the hospital.

The immune system can remain weak for an extended period, particularly after an allogeneic transplant.

Follow-up may involve:

• Regular blood tests
• Medication adjustments
• Infection monitoring
• Immunosuppressive medicines where required
• Vaccination planning
• Nutritional support
• Monitoring for GVHD
• Bone marrow assessment when indicated
• Monitoring for disease recurrence

Patients travelling home after BMT should leave India with a written treatment summary and a clear follow-up schedule.

The Indian transplant team and the patient's local doctor should have a clear communication plan.

What Should Overseas Patients Budget Beyond the BMT Cost?

The hospital quotation is not the entire medical-travel budget.

Families should also plan for:

Travel expenses

• Flights
• Airport transfers
• Local transport

Accommodation

The patient may need accommodation near the hospital before admission and after discharge.

Attendant expenses

A family member may need to stay with the patient throughout the treatment period.

Food and daily expenses

Dietary requirements can become more specific during recovery.

Additional medical costs

Budget for tests or medicines that may not be included in the initial package.

Emergency reserve

It is sensible to keep additional funds available because complications can extend hospitalisation.

For this reason, an overseas family should compare the total expected treatment budget, not just the advertised BMT package.

How HealthRoop Helps Overseas BMT Patients

For an overseas patient, arranging a transplant involves medical reports, specialist opinions, hospital selection, donor evaluation, travel arrangements and follow-up planning. HealthRoop's BMT service connects these parts so the patient can approach the appropriate transplant centre with the necessary medical information already organised.

• Review and organisation of medical reports
• Assistance in identifying an appropriate BMT hospital
• Specialist consultation coordination
• Second-opinion assistance
• Treatment estimate coordination
• Hospital appointment scheduling
• Medical visa and travel assistance
• Airport and accommodation coordination
• Support with donor-related coordination
• Communication with the hospital during treatment
• Follow-up consultation coordination after returning home

The actual treatment decision remains with the treating haematologist or transplant team after reviewing the patient's medical records.

How to Prepare for BMT in India

A practical preparation checklist can make the process easier.

Before Leaving Your Home Country

• Collect all medical records.
• Ask your current doctor for a treatment summary.
• Obtain digital copies of pathology and imaging.
• Ask whether HLA testing has already been completed.
• Prepare a list of current medicines.
• Identify the likely transplant type if already advised.
• Send the records to the Indian transplant centre.
• Request a written treatment estimate.
• Confirm visa requirements.
• Plan accommodation for the expected treatment period.

Before Hospital Admission

• Confirm admission date.
• Confirm donor availability.
• Ask which investigations must be repeated.
• Confirm payment requirements.
• Understand what the package includes.
• Ask about isolation and visitor rules.
• Confirm who will coordinate your case.
• Keep copies of all hospital correspondence.

Common Mistakes to Avoid

Selecting a Hospital Only by Price

The lowest quotation may not provide the right transplant programme for a particular disease.

Comparing Different Transplants as if They Were the Same

Autologous and allogeneic transplantation have different requirements, risks and costs.

Travelling Before Medical Review

Do not book a long treatment trip based only on an online estimate.

Ignoring Donor Matching

For allogeneic BMT, donor compatibility is a central part of planning.

Assuming the First Quote Is the Final Bill

Ask what happens if hospitalisation becomes longer or complications develop.

Leaving India Without a Follow-Up Plan

BMT requires continued monitoring. Make sure the hospital provides treatment summaries and follow-up instructions before departure.

Final Thoughts

Bone marrow transplantation requires careful planning because the treatment extends well beyond the day the stem cells are infused. For an overseas patient, the medical plan, donor assessment, hospital stay, infection precautions, follow-up and travel arrangements all need to be considered together.

The bone marrow transplant cost in India can be attractive compared with treatment in many other countries, but price should not be the main reason for selecting a transplant centre. The more important questions are whether the hospital has appropriate transplant expertise, whether the recommended treatment fits the patient's condition, how donor matching will be handled and what support is available during recovery.

A sensible first step is to send the complete medical record to the transplant team. Once the doctors have reviewed the diagnosis, previous treatment and donor information, they can advise whether BMT is appropriate, which type may be considered and what investigations are required before treatment.

Price Disclaimer: The cost figures in this article are indicative planning ranges based mainly on previously published 2025-era Indian healthcare and BMT cost information. They are not fixed or current hospital quotations. Actual prices can change because of transplant type, donor matching, HLA testing, medicines, hospital stay, complications, ICU requirements and the patient's medical condition. For exact and current pricing, overseas patients should call or email HealthRoop or the selected hospital and request a case-specific quotation after medical-record review.

Medical Disclaimer: This article is intended for general educational purposes only. It does not replace an individual consultation with a qualified haematologist or bone marrow transplant specialist. BMT may not be appropriate for every patient, and treatment decisions should be made after reviewing the patient's diagnosis, disease status, previous treatment and overall health.